Emma Andrus, Associate Editor

Nemolizumab is intended for use in combination with topical corticosteroids and/or calcineurin inhibitors in this indication.

The approval is based on positive data stemming from the ADORING clinical trial program.

A study using proteome-wide association techniques identified novel protein biomarkers for atopic dermatitis.

Dena Antowan shares her journey balancing pre-med life, managing HS, advocating on TikTok, and her vision for empathetic dermatologic care.

Investigating podiatry students' diagnostic accuracy and reasoning for dermatological lesions across skin tones using a mixed-method research approach.

Explore key insights and innovations in vitiligo from 2024, from treatment advances to patient-focused strategies.

Dermatology Times asked our readers to share what conferences they are looking forward to in the fourth quarter of 2024.

Dermatology Times is looking back on the top stories in dermatology from the month of November.

Dermatology Times is recapping our top expert interviews from the month of November.

Data from Galderma's OLYMPIA 1 trial was recently published in JAMA Dermatology.

This study demonstrates the use of AI-driven image analysis, leveraging the ScarletredVision app and machine learning, to diagnose and assess onychomycosis.

Researchers recommend limiting routine lipase tests to symptomatic patients or those with radiographic signs of pancreatic injury.

The LIBERO study confirmed brodalumab is effective in managing psoriasis in patients over 100 kg, showing comparable long-term benefits in patients under 100 kg.

Andrea Rosik, MS, PA-C, provides insights into managing challenging cases of atopic dermatitis.

The study is set to begin enrollment later this year.

ENS-002 targets S. aureus in atopic dermatitis.

2-year data show 75.7% of TNFi-IR patients maintained ACR50, 80.6% achieved PASI100, and pain and fatigue improvements were sustained.

The ILDS has named 6 young dermatologists from around the world as recipients of the 2025 Young Dermatologists International Achievement Awards for their contributions to dermatology.

In a Dermatology Times Case-Based Peer Perspective event, Terry Faleye, MPAS, PA-C, reviewed 2 cases of patients with vitiligo to discuss innovative treatments and emotional challenges with disease management.

A study showed NB-UVB phototherapy effectively reduced prurigo nodularis symptoms, with 80% of patients achieving full response.

RAD will join MJH's multichannel model, enhancing its educational impact in atopic dermatitis, alopecia areata, vitiligo, and eczema.

Abeona's pz-cel has been granted a April 29, 2025, PDUFA date.

Catch up on coverage from the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.

Catch up on coverage from the fourth and final day of the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.

Discover top innovations, insights, and clinical pearls from Elevate-Derm in Scottsdale, where top insights for advanced practice providers took center stage.

At Elevate-Derm West, Murase shared promising results in treating severe itch with emerging therapies, offering hope for patients with few options.

Swanson shared practical tips from her Elevate-Derm West sessions, empowering clinicians with new strategies for pediatric skin care.

Marghoob shares key dermoscopic features to help clinicians identify benign vs malignant lesions on various locations of the body.

Catch up on coverage from the third day of the 2024 Elevate-Derm West Conference in Scottsdale, Arizona.

Delgocitinib cream offers a safe, low-systemic-exposure option for chronic hand eczema, according to a poster from the Elevate-Derm conference.